Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework
Supportive Care in Cancer · 2026-07 · 34 (7)
DOI: 10.1007/s00520-026-10987-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Supportive Care in Cancer, online erschienen am 07.07.2026. Verfasst von Mellar P Davis. Beteiligte Einrichtung: Levine Cancer Institute, Advocate Health, Charlotte, NC, USA. Mellar.Davis@advocatehealth.org. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders, Neoplasms, Substance Abuse Detection. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Levine Cancer Institute, Advocate Health, Charlotte, NC, USA. Mellar.Davis@advocatehealth.org.
Zitieren
APA
Davis, M. P. (2026). Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework. Supportive Care in Cancer, 34(7). https://doi.org/10.1007/s00520-026-10987-2
Vancouver
Davis MP. Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework. Supportive Care in Cancer. 2026;34(7). doi:10.1007/s00520-026-10987-2
BibTeX
@article{Davis2026,
author = {Davis, Mellar P},
title = {Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {7},
doi = {10.1007/s00520-026-10987-2}
}
EUVIMED